Patent · US Active

CD80 and CD86 binding protein compositions and uses thereof

US12227557B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignees

OncoC4, Inc. · US
CHILDREN'S NATIONAL MEDICAL CENTER · US

Inventors

Yang Liu · Columbus, US
Pan Zheng · Ann Arbor, US
Martin Devenport · Gaithersburg, US
Wei Wu · Washington, US
Xuexiang Du · Baltimore, US
Mingyue Liu · Shanghai, CN
Fei Tang · Washington, US

Key dates

Filing date	Feb 22, 2022
Grant date	Feb 18, 2025
Priority date	—
Expiry date	Aug 13, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to CTLA-4 protein compositions and their use in the mitigation of autoimmune adverse events associated with cancer immunotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.